Prot # CP-4-005: A Phase 3, Multicenter Study Designed to Evaluate the Efficacy and Safety of a Long Acting hGH Product (MOD-4023) in Adult Subjects with Growth Hormone Deficiency

Project: Research project

Project Details

StatusFinished
Effective start/end date8/22/13 → 8/21/18

Funding

  • inVentiv Health Clinical (Prot # CP-4-005)
  • Prolor Biotech Ltd. (Prot # CP-4-005)